Featured Article
Antidepressants Becoming a Bigger Problem for Patients and the Recovery Industry is Going to Have to Help Solve It
Antidepressants Becoming a Bigger Problem for Patients and the Recovery Industry is Going to Have to Help Solve It

Millions of patients taking antidepressants (selective serotonin reuptake inhibitors, or SSRIs) experience terrible side effects when they try to cut down or stop taking them altogether, says a report from Britain's elite All Party Parliamentary Group for Prescribed Drug ...

Read More

Blog posts in October

  • One in Three Outpatient Opioid Prescriptions Have No Documented Pain Diagnosis

    Nearly a third of all outpatient opioid prescriptions in America are written with no medical reason documented in patient records to justify the ...

    View More
  • FDA Approves New Sublingual Films to Treat Opioid Dependence

    The FDA has approved a new 16 mg/4 mg buprenorphine-naloxone sublingual film to treat opioid dependence. Called Cassipa, it is made by Teva ...

    View More
  • Opioid treatment outcomes are worse for women: Study

    Women are not getting the kind of opioid addiction treatment they should be getting. That’s not because women aren’t loved or appreciated. It’s ...

    View More
  • Senate Passes Sweeping Bipartisan Opioid Bill

    In a strongly bipartisan 98-1 vote, the Senate has approved massive new legislation aimed at combating the opioid epidemic, and sent it on to the ...

    View More
  • Most older adults aren't counseled on leftover opioids

    Do you ever just take some of an opioid prescription, and then hang on to what’s left over in case you want it sometime in the future? This is not ...

    View More
  • Alcohol Causes Over Five Percent of Deaths Worldwide

    A study from the UN's World Health Organization (WHO) has revealed that more than 3 million people died in 2016 as a result of the harmful use of ...

    View More

Start Your New Path to Sobriety Today!

    • Please enter your name.
    • This isn't a valid phone number.
    • Please enter your email address.
      This isn't a valid email address.
    • Please make a selection.
    • Please enter a message.